本页面由Tiger Trade Technology Pte. Ltd.提供服务

NovoCure Limited

12.11
+0.35002.98%
盘后12.09-0.0200-0.17%19:35 EST
成交量:225.49万
成交额:2,711.88万
市值:13.56亿
市盈率:-7.53
高:12.21
开:11.85
低:11.74
收:11.76
52周最高:34.13
52周最低:10.70
股本:1.12亿
流通股本:9,414.79万
量比:1.04
换手率:2.40%
股息:- -
股息率:- -
每股收益(TTM):-1.6074
每股收益(LYR):-1.5638
净资产收益率:-50.60%
总资产收益率:-8.30%
市净率:3.97
市盈率(LYR):-7.74

数据加载中...

2025/12/01

重要事件披露

Form 8-K - Current report
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/07/24

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/24

重要事件披露

Form 8-K - Current report
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/24

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/24

重要事件披露

Form 8-K - Current report